Literature DB >> 12653398

African-American heredity prostate cancer study: a model for genetic research.

I J Powell1, J Carpten, G Dunston, R Kittles, J Bennett, G Hoke, C Pettaway, S Weinrich, S Vijayakumar, C A Ahaghotu, W Boykin, T Mason, C Royal, A Baffoe-Bonnie, J Bailey-Wilson, K Berg, J Trent, F Collins.   

Abstract

A genome-wide scan of high-risk prostate cancer families in North America has demonstrated linkage of a particular marker to Chromosome 1q (HPC1). An even greater proportion of African-American families have shown linkage to HPC1. Therefore, investigators at the National Human Genome Research Institute (NHGRI) in collaboration with Howard University and a predominantly African-American group of urologists established the African-American Hereditary Prostate Cancer (AAHPC) Study Network to confirm the suggested linkage of HPC in African Americans with a gene on Chromosome 1. Blood samples from recruited families were sent to Howard University for extraction of DNA. The DNA was sent to NHGRI at NIH where the genotyping and genetic sequence analysis was conducted. Genotype data are merged with pedigree information so that statistical analysis can be performed to establish potential linkage. From March 1, 1998, to June 1, 1999, a total of 40 African-American families have been recruited who met the study criteria. Preliminary results suggest that racial/ethnicity grouping may affect the incidence and extent of linkage of prostate cancer to specific loci. The importance of these findings lays in the future treatment of genetic-based diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12653398      PMCID: PMC2593987     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.

Authors:  P Berthon; A Valeri; A Cohen-Akenine; E Drelon; T Paiss; G Wöhr; A Latil; P Millasseau; I Mellah; N Cohen; H Blanché; C Bellané-Chantelot; F Demenais; P Teillac; A Le Duc; R de Petriconi; R Hautmann; I Chumakov; L Bachner; N J Maitland; R Lidereau; W Vogel; G Fournier; P Mangin; O Cussenot
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.

Authors:  J R Smith; D Freije; J D Carpten; H Grönberg; J Xu; S D Isaacs; M J Brownstein; G S Bova; H Guo; P Bujnovszky; D R Nusskern; J E Damber; A Bergh; M Emanuelsson; O P Kallioniemi; J Walker-Daniels; J E Bailey-Wilson; T H Beaty; D A Meyers; P C Walsh; F S Collins; J M Trent; W B Isaacs
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

3.  Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25.

Authors:  R A McIndoe; J L Stanford; M Gibbs; G P Jarvik; S Brandzel; C L Neal; S Li; J T Gammack; A A Gay; E L Goode; L Hood; E A Ostrander
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

4.  Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer.

Authors:  M Gibbs; L Chakrabarti; J L Stanford; E L Goode; S Kolb; E F Schuster; V A Buckley; M Shook; L Hood; G P Jarvik; E A Ostrander
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

5.  Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study.

Authors:  K A Cooney; J D McCarthy; E Lange; L Huang; S Miesfeldt; J E Montie; J E Oesterling; H M Sandler; K Lange
Journal:  J Natl Cancer Inst       Date:  1997-07-02       Impact factor: 13.506

6.  Evidence for a prostate cancer susceptibility locus on the X chromosome.

Authors:  J Xu; D Meyers; D Freije; S Isaacs; K Wiley; D Nusskern; C Ewing; E Wilkens; P Bujnovszky; G S Bova; P Walsh; W Isaacs; J Schleutker; M Matikainen; T Tammela; T Visakorpi; O P Kallioniemi; R Berry; D Schaid; A French; S McDonnell; J Schroeder; M Blute; S Thibodeau; H Grönberg; M Emanuelsson; J E Damber; A Bergh; B A Jonsson; J Smith; J Bailey-Wilson; J Carpten; D Stephan; E Gillanders; I Amundson; T Kainu; D Freas-Lutz; A Baffoe-Bonnie; A Van Aucken; R Sood; F Collins; M Brownstein; J Trent
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

  6 in total
  4 in total

1.  Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.

Authors:  Kathleen Mastalski; Elliot J Coups; Karen Ruth; Susan Raysor; Veda N Giri
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

2.  Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.

Authors:  Christiane M Robbins; Wenndy Hernandez; Chiledum Ahaghotu; James Bennett; Gerald Hoke; Terry Mason; Curtis A Pettaway; Srinivasan Vijayakumar; Sally Weinrich; Paulette Furbert-Harris; Georgia Dunston; Isaac J Powell; John D Carpten; Rick A Kittles
Journal:  Prostate       Date:  2008-12-01       Impact factor: 4.104

3.  Conducting Precision Medicine Research with African Americans.

Authors:  Chanita Hughes Halbert; Jasmine McDonald; Susan Vadaparampil; LaShanta Rice; Melanie Jefferson
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

Review 4.  Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.

Authors:  Shyh-Han Tan; Gyorgy Petrovics; Shiv Srivastava
Journal:  Int J Mol Sci       Date:  2018-04-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.